Inventiva S.A. (IVA)
NASDAQ: IVA · Real-Time Price · USD
3.650
-0.080 (-2.14%)
At close: Oct 30, 2026, 4:00 PM EDT
3.720
+0.070 (1.92%)
After-hours: Oct 30, 2026, 7:50 PM EDT
Inventiva Market Cap
Inventiva has a market cap or net worth of $838.96 million as of October 30, 2026. Its market cap has increased by 37.38% in one year.
Market Cap
838.96M
Enterprise Value
808.43M
1-Year Change
37.38%
Global Rank
n/a
Country Rank
n/a
Category
ChartMarket Cap Chart
Since July 10, 2020, Inventiva's market cap has increased from $547.96M to $838.96M, an increase of 53.11%. That is a compound annual growth rate of 6.98%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 838.96M | -5.19% |
| Dec 31, 2025 | 884.84M | 309.83% |
| Dec 31, 2024 | 215.91M | -7.64% |
| Dec 29, 2023 | 233.77M | 16.05% |
| Dec 30, 2022 | 201.44M | -63.07% |
| Dec 31, 2021 | 545.53M | -0.85% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MeiraGTx Holdings | 944.10M |
| Alto Neuroscience | 942.60M |
| Ginkgo Bioworks Holdings | 934.01M |
| Alumis | 933.23M |
| Jade Biosciences | 922.80M |
| Corvus Pharmaceuticals | 893.79M |
| Arbutus Biopharma | 859.65M |
| Pharming Group | 850.99M |